Does PEMBROLIZUMAB Cause Supraventricular tachycardia? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Supraventricular tachycardia have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.1% of all adverse event reports for PEMBROLIZUMAB.
50
Reports of Supraventricular tachycardia with PEMBROLIZUMAB
0.1%
of all PEMBROLIZUMAB reports
8
Deaths
35
Hospitalizations
How Dangerous Is Supraventricular tachycardia From PEMBROLIZUMAB?
Of the 50 reports, 8 (16.0%) resulted in death, 35 (70.0%) required hospitalization, and 6 (12.0%) were considered life-threatening.
Is Supraventricular tachycardia Listed in the Official Label?
Yes, Supraventricular tachycardia is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Supraventricular tachycardia?
ADALIMUMAB (141)
METOPROLOL (132)
ROSIGLITAZONE (114)
TREPROSTINIL (113)
RITUXIMAB (99)
ALBUTEROL (98)
IBRUTINIB (96)
DEXAMETHASONE (95)
ASPIRIN (92)
LEVOTHYROXINE (91)
Which PEMBROLIZUMAB Alternatives Have Lower Supraventricular tachycardia Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G